FDA.reportPublic FDA data

dapagliflozin propanediol

RxCUI
1486966
RxNorm name
dapagliflozin propanediol
Term type
PIN
Status
Active
Updated
2026-08-12 12:30:20

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022014
Active start
022014
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
dapagliflozin1488564

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdapagliflozin propanediol1NAMES
RxNorm Namedapagliflozin propanediol1NAMES
TTYPIN1ATTRIBUTES
SPL_SET_ID
11 linked values
11CODES
UNII_CODE887K2391VH1CODES
RxCUI14869661CODES
MMSL_CODEIN299861CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 2 matching rows.

UNII, Preferred term, Registry number table
UNIIPreferred termRegistry numberSource
887K2391VHDAPAGLIFLOZIN PROPANEDIOL960404-48-2tbl_unii_list
887K2391VHDAPAGLIFLOZIN PROPANEDIOL960404-48-2tbl_unii_list

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FARXIGADAPAGLIFLOZINA-S Medication Solutions01f90c94-71cb-4a1f-81ff-8004b850529b2026-07-10Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
FARXIGADAPAGLIFLOZINAstraZeneca Pharmaceuticals LP72ad22ae-efe6-4cd6-a302-98aaee423d692026-06-03Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
DAPAGLIFLOZINDAPAGLIFLOZINPrasco Laboratories3aba33aa-f8c6-4b10-85c8-dfa14578d07c2026-06-03Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
FARXIGADAPAGLIFLOZINREMEDYREPACK INC.ef9e9c8c-5460-4193-952a-0c249dd071bd2026-04-24Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
DAPAGLIFLOZINDAPAGLIFLOZINCipla USA Inc.a2f86c0a-ce78-4d06-b5d8-ed457c8e36142026-04-08Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
dapagliflozin and metformin hydrochlorideDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDEPrasco Laboratorieseaf135b6-e378-4f62-a1e7-db45e23668c72024-12-20Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
XIGDUO XRDAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDEAstraZeneca Pharmaceuticals LPac8a0f7b-9f69-4495-abbc-3a47cd75a8592024-12-20Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
DAPAGLIFLOZINDAPAGLIFLOZINBryant Ranch Prepack979205ee-b0b8-4483-ae61-f283f750bb7f2024-08-08Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
DAPAGLIFLOZINDAPAGLIFLOZINA-S Medication Solutions82cdd5ad-df2b-4bdd-a3a6-a059040100b42024-06-28Warnings, Adverse reactionsExact identifier
unii: 887K2391VH
DAPAGLIFLOZINDAPAGLIFLOZINA-S Medication Solutions87521963-0d2a-4a2a-89c6-d50e8582419e2024-06-28Warnings, Adverse reactionsExact identifier
unii: 887K2391VH

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA10BKSodium-glucose co-transporter 2 (SGLT2) inhibitorsATC1-4dapagliflozin
FDASPLN0000187059Sodium-Glucose Cotransporter 2 InhibitorEPChas_epcdapagliflozin
FDASPLN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientdapagliflozin
MEDRTD005960GlucosidesCHEMhas_ingredientdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin propanediol
MEDRTD004342Drug HypersensitivityDISEASEci_withdapagliflozin propanediol
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin
MEDRTD051437Renal InsufficiencyDISEASEci_withdapagliflozin propanediol
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin propanediol
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin propanediol
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin propanediol
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
CODESSNOMEDCT703675000
CODESUSPm9215
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUnited States Pharmacopeia
SOURCESSourceUS Edition of SNOMED_CT